About this Event
Join ACHENTX and Quest Diagnostics for a high-impact networking event featuring a dynamic panel on digital pathology and AI in the lab – where you’ll gain real-world insights, connect with forward-thinking leaders, and explore how emerging technologies are reshaping diagnostics, driving efficiency, and improving patient outcomes.
Speakers:
Viv Babber, MD
CEO
Lean Six Intelligence Group
Dr. Mark Kruzel
Medical Director for Oncology and Consumer-Initiated Testing
Quest Diagnostics
A big thanks to Quest Diagnostics for hosting this event for us! Light refreshments and hors d’oeuvres will be available.
Speakers' Bios:
Dr. Viv Babber is a physician leader and AI governance and responsible AI strategist with over 20 years of clinical and healthcare leadership experience. She holds advanced certifications in AI Medicine and AI Ethics, and has earned the AI Governance Professional (AIGP) designation from the International Association of Privacy Professionals. She has achieved a unique, visionary, and forward-thinking milestone with ISO/IEC 42001 Lead Auditor certification for global AI management systems (AIMS), positioning her among early leaders shaping the adoption of a rapidly emerging standard that supports structured AI governance, AI risk management, audit readiness, and regulatory compliance for organizations deploying AI.
A Lean Six Sigma Black Belt, Dr. Babber applies a disciplined, systems-driven approach grounded in process optimization, risk reduction, and operational efficiency to help healthcare systems, life sciences, and digital health companies implement safe, scalable, and compliant healthcare AI and enterprise AI solutions, including EHR-integrated AI. As an educator, advisor, and speaker, she positions AI governance as critical infrastructure, guiding medical and legal professionals to strengthen trust, safeguard privacy, and ensure safe, accountable AI adoption in high-stakes, high-trust environments. She is a member of the Forbes Coaches Council and has been recognized as an AI75 Impact Innovator among leading AI voices in North Texas for advancing responsible, enterprise-ready AI. A trusted thought leader, her articles and AI On Call newsletter deliver clear, executive-level insights that inform decision-making across AI governance, compliance, and AI risk.
Mark Kruzel, MD, MBA serves as Medical Director for Oncology and Consumer-Initiated Testing at Quest Diagnostics. In these roles, he leads strategic efforts to expand access to high-quality diagnostics and advance precision medicine. In his consumer-initiated testing work, Dr. Kruzel focuses on designing clinically responsible patient-centered testing models that empower individuals while maintaining strong integration with the clinician care continuum. His approach reflects a nuanced understanding of the patient–physician relationship alongside a sophisticated appreciation for the operational, financial, and strategic dimensions—the business and the art—of modern medicine.
Dr. Kruzel also serves as a medical liaison to the organization’s national payers, partnering on reimbursement strategy and evidence development to support coverage for clinically actionable testing pathways. His work spans the full diagnostic lifecycle—from assay development, validation and clinical utility—while emphasizing appropriate utilization and the implementation of guideline-driven care pathways.
Deeply committed to improving health outcomes, Dr. Kruzel is particularly passionate about expanding equitable access to diagnostics for underserved populations. He is passionate about advancing testing pathways that are precise, efficient, and capable of informing meaningful clinical decisions.
With extensive experience across research and industry, Dr. Kruzel has managed an FDA clinical trial site and contributed to the commercialization of a novel therapeutic within a startup environment. He has authored multiple peer-reviewed publications and presented at regional and national conferences, and he continues to pursue scholarship focused on diagnostic access, payer engagement, and innovative testing models.
He is an active member of the American Society of Clinical Oncology (ASCO), the Association for Molecular Pathology (AMP), and the American College of Healthcare Executives (ACHE). Dr. Kruzel earned his medical degree from McGovern Medical School at The University of Texas Health Science Center at Houston and holds a Master of Business Administration from the Cox School of Business at Southern Methodist University.
Event Venue & Nearby Stays
Quest Diagnostics, 2501 South State Highway 121, Suite 1100, Lewisville, United States
USD 38.41 to USD 64.92
